Simon Völkl

机构：Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Cancer Research Center, Centro de Investigación del Cáncer, Comprehensive Cancer Center Erlangen · ORCID：0000-0003-2193-3048

发表论文 164 篇 · 总被引 6648 次 · h-index 39

代表论文

CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024 · The Lancet Rheumatology · 被引 122)
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study (2025 · The Lancet Rheumatology · 被引 90)
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025 · Nature Medicine · 被引 79)
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial (2026 · Nature Medicine · 被引 67)
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis (2025 · New England Journal of Medicine · 被引 56)
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma (2025 · Blood · 被引 42)